Appealing for efficient, well organized clinical trials on COVID-19.

ABSTRACT:

Background

The rapid emergence of clinical trials on COVID-19 stimulated a wave of discussion in scientific community. It is important to understand the characteristics of the ongoing or pending interventional clinical trials on COVID-19.

Methods

We reviewed the characteristics of interventional trials from Chinese Clinical Trial Registration (ChiCTR) and ClinicalTrials.gov. A total of 171 COVID-19-related interventional trials were identified on Feb 22, 2020. These trials are classified into 4 categories based on treatment modalities, including chemical drugs (CDs), biological therapies (BTs), traditional Chinese medicine (TCM) treatments and other therapies.

Results

Our analysis focused on the issues of stage, design, randomization, blinding, primary endpoints (PEs)

SUBMITTER: Zhao Y 

PROVIDER: S-EPMC7290614 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature